The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases

Medical Decision Making - United States
doi 10.1177/0272989x14563082
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

SAGE Publications

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy